NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000425

Registered date:30/06/2006

Comparison of latanoprost and timolol in the treatment for exfoliation glaucoma: A randomized controlled trial.

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedExfoliation glaucoma
Date of first enrollment2006/04/01
Target sample size60
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Latanoprost 1 per day for 3 months Timolol 2 per day for 3 months

Outcome(s)

Primary OutcomeIntraocular pressure after 3 months
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum40years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1. Severe visual field defect. 2. The treatment with latanoprost or timolol within the last 28 days. 3. Allergy to latanoprost or timolol. 4. The past histories of intraocular surgery within the last 3 months or glaucoma surgery. 5. The patients with asthma, heart failure, severe diabetes mellitus or pregnancy. 6. The patients who participated in another drug study within 30 days. 7. Judged inappropriate for this study by the physicians.

Related Information

Contact

public contact
Name
Address Japan
Telephone
E-mail inatani@u-fukui.ac.jp
Affiliation Kumamoto University Graduate School of Medical Sciences Department of Ophthalmology and Visual Science
scientific contact
Name Masaru Inatani
Address 1-1-1Honjo Kumamoto, 860-8556 Japan Japan
Telephone
E-mail
Affiliation Kumamoto University Graduate School of Medical Sciences Department of Ophthalmology and Visual Science